CARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21

Bulletin Express

Yesterday

CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.

Mr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.

Following the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.

As of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1137766883"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137766883\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137766883?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-30 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137766883","market":"hk","top_or_hot":-1,"title":"CARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21","media":"Bulletin Express","content":"<p>CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.</p>\n<p>Mr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.</p>\n<p>Following the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.</p>\n<p>As of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCARsgen Therapeutics Reports Director Resignation and Audit Committee Shortfall Under HKEX Rule 3.21\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-30 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.</p>\n<p>Mr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.</p>\n<p>Following the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.</p>\n<p>As of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1137766883","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137766883","pubTimestamp":1790775766,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"CARsgen Therapeutics 根据港交所规则 3.21 报告董事辞职和审计委员会人手不足","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARsgen Therapeutics Holdings Limited announced that Non-Executive Director Mr. Huaqing Guo resigned with effect from 30 September 2026 to focus on other business commitments. His departure also ends his role as a member of the company’s Audit Committee.\nMr. Guo confirmed he has no outstanding claims against the company and no disagreements with the Board. The Board expressed gratitude for his tenure and contributions.\nFollowing the resignation, the Audit Committee now consists of two independent non-executive directors—Ms. Xiangke Zhao (chairperson) and Dr. Wen Zhou—leaving the committee below the minimum three-member requirement stipulated by Hong Kong Listing Rule 3.21. The Board aims to appoint a suitable replacement within three months to restore compliance.\nAs of the announcement date, CARsgen’s Board comprises three executive directors (Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang), one remaining non-executive director (Mr. Ronggang Xie) and three independent non-executive directors (Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}